73% of Peptide Suppliers Fail This Test. Here's How to Check.

Important Disclaimer: The information on this site is for educational and research purposes only. Peptides discussed here are not approved by the FDA for human use outside of clinical trials. They are sold strictly for laboratory and research purposes. This is not medical advice. Always consult a licensed healthcare professional before considering any peptide, supplement, or research compound. We do not endorse or recommend personal use.

How to Read a Peptide COA: HPLC, Purity & Red Flags

You ordered from a supplier. The vial arrives. A Certificate of Analysis is attached, or linked, or buried in an email. It shows 99.2% purity and a molecular weight that looks roughly right. You figure that checks out and move on.

That assumption is costing researchers real money and potentially real experimental integrity.

Independent laboratory data analyzed between 2024 and early 2026 found that 73% of peptide samples submitted for third-party verification showed measurable purity discrepancies compared to the supplier's Certificate of Analysis, with an average gap of 8.4 percentage points below what was claimed (ACS Peptide Testing Labs, 2026). In the GLP-1 peptide category specifically, that discrepancy rate climbed to 81%. Only 27% of supplier-provided COAs matched independent results exactly.

Those numbers are not an indictment of every supplier in the space. Many operate transparently and produce accurate documentation. But they do tell you something important: a COA is not a guarantee. It is a document. And like any document, its value depends entirely on whether you know how to read it, who produced it, and what it is actually measuring vs. what it is not.

The peptide research community has a documented literacy gap here. The most common questions in r/Peptides and r/biohacking are not about which compounds to research. They are about how to know if what you have is actually what the label says. That question has a systematic answer. This is it.

This guide explores how to read a peptide COA from the top-line purity number down to the fine-print tests most researchers skip, with a specific focus on the one distinction almost every beginner gets wrong: HPLC purity and net peptide content are not the same thing, and confusing them means your research dosing math is off before you even start.

What a Certificate of Analysis Actually Is

A Certificate of Analysis is a formal analytical document prepared by a laboratory confirming that a specific batch of research compound meets defined quality parameters. For peptides, the COA documents the results of chemical testing performed on that particular lot, including identity, purity, and often additional safety or composition metrics (Numan, Verified Peptides, 2025).

The key phrase is "specific batch." A legitimate COA is lot-matched, meaning it was generated from testing of the exact material in the vial you received. It is not a template document applied broadly across a product line. The lot number on your vial should match the lot number on the COA. If it does not, you have no analytical evidence that applies to your material.

COAs can be generated by two types of laboratories:

Supplier in-house testing: The vendor tests their own product using internal quality control systems. This is common and not inherently problematic, but it introduces a conflict of interest. In-house testing can be rigorous or can be designed to pass.

Third-party independent testing: An external, accredited laboratory analyzes the peptide independently with no financial incentive tied to the outcome. The most credible third-party labs carry ISO 17025:2017 accreditation, the international standard for analytical laboratory competence. Well-known third-party testing providers in the peptide research space include Janoshik, Intertek, Eurofins, and SGS.

Key Insight: Third-party COAs from ISO 17025-accredited labs provide the highest confidence because the lab has no stake in the result. A supplier whose documentation comes exclusively from their own in-house testing is asking you to trust both the product and the document simultaneously.

The Architecture of a COA: What Each Section Tells You

A complete research-grade peptide COA should contain six core categories of information. Walk through each when evaluating a new supplier or a new batch.

1. Header and Batch Identification

Before looking at a single test result, verify the basics:

• Product name and sequence: Is this exactly the peptide you ordered, with the correct amino acid sequence spelled out?
• Lot or batch number: Should match what is physically on your vial. This is non-negotiable.
• Date of analysis: When was this testing performed? A COA dated from years ago on a current batch is a problem.
• Salt form: Is the peptide supplied as a trifluoroacetate (TFA) salt, acetate salt, or free base? This matters for net peptide content calculations and storage.
• Storage recommendations: Should specify temperature (typically freeze at -20°C or -80°C), protection from light, and moisture conditions.
• Analyst signature and lab name: Who performed this testing and where?

If any of these are vague, missing, or generic, stop here. The rest of the document cannot be trusted if the header does not tie the analysis to a specific, identifiable batch.

2. HPLC Purity: What That Percentage Actually Measures

This is the number almost everyone looks at first. It is also the most misunderstood.

High-Performance Liquid Chromatography (HPLC) works by pushing a dissolved peptide sample through a specialized column under high pressure. Different molecular species travel through the column at different speeds based on their chemical properties, primarily hydrophobicity in the reverse-phase method used for most peptides. As each component exits the column, a UV detector measures absorbance, generating the chromatogram graph you see on a COA.

The purity percentage is calculated as:

(Area of the target peptide peak) ÷ (Total area of all UV-absorbing peaks) × 100

What this tells you: what proportion of the UV-absorbing, peptide-related content in the vial is your target compound versus synthesis byproducts, truncated sequences, deletion fragments, and oxidation products.

What this does NOT tell you: anything about water content, salt content, or non-UV-absorbing contaminants. This distinction is the source of the most consequential misunderstanding in peptide research dosing.

Purity benchmarks for research grade:

Key Insight: A peptide can report 99% HPLC purity and still be only 70–80% actual peptide by weight, because HPLC does not measure water, salts, or counter-ions. This is why the purity number and the net peptide content number are different, and why confusing them leads to systematic dosing errors in laboratory work.

Reading the Chromatogram

Many high-quality COAs include the actual HPLC chromatogram image rather than just reporting the purity percentage. When you have access to it, look for:

• One dominant peak representing your target peptide (should account for the stated purity percentage of total peak area)
• Minimal secondary peaks; any peak greater than 1–2% of total area represents a meaningful impurity
• Clean baseline between peaks, not a continuous hump of unresolved material
• Retention time noted, which provides reproducibility evidence across batches

Some reputable third-party labs, including Janoshik, report numerical purity results without attaching the chromatogram image. This does not automatically invalidate the result, but for a new supplier, requesting the chromatogram file is best practice to confirm the number reflects real analytical data and not a typed estimate.

3. Mass Spectrometry: Confirming You Have the Right Peptide

Here is a scenario that should unsettle you: a peptide could be 99% pure and 100% the wrong molecule. HPLC measures purity relative to the UV-absorbing content present. It does not confirm that the dominant peak is actually the peptide you intended to order. A deletion peptide, one missing a single amino acid, might look nearly identical on HPLC but would be biologically inert or unpredictably different.

Mass Spectrometry (MS) solves this problem. It measures the precise molecular weight of the compound and confirms whether the observed mass matches the theoretical mass of your intended peptide sequence.

The COA will list:

• Theoretical molecular weight: The calculated mass of the correct peptide sequence
• Observed molecular weight: What the instrument measured from your actual sample

These should match within the instrument's margin of error, typically within 1 Dalton for smaller peptides or expressed as parts-per-million for high-resolution instruments.

Common MS notation on COAs:

The most common reason a COA shows MS data that looks "off" is multiply charged ions, particularly for larger peptides. A 3,000 Da peptide appearing at m/z 1501 is simply the doubly charged form and is normal. If you see an unexplained mass shift with no charge state explanation, that is a genuine red flag.

Most third-party testing providers combine HPLC and MS in a single test report. If the mass does not match, the lab typically flags it clearly. Always confirm that your testing provider is actually running MS, not just HPLC alone.

Key Insight: HPLC tells you how pure your sample is. Mass spectrometry tells you what it actually is. Both tests are required for a complete quality verification. A COA with only one of the two is incomplete.

4. Net Peptide Content: The Number Most Researchers Miss

This is the most important section in the COA that most researchers skip entirely, and it is the source of the most consequential dosing errors in peptide research.

The distinction that matters:

HPLC Purity = percentage of the sample that is your target peptide compared to other peptide-like impurities

Net Peptide Content (NPC) = percentage of the total vial weight that is actual peptide, accounting for water, salts, counter-ions, and residual solvents

A vial labeled as containing 5 mg of peptide at 99% HPLC purity might contain only 3.5 to 4.2 mg of actual peptide by weight, with the remainder being bound water (lyophilized peptides are hygroscopic and absorb moisture), TFA or acetate salt counter-ions from the synthesis process, and residual synthesis solvents.

Typical NPC ranges by amino acid composition:

• Peptides rich in lysine (K) and arginine (R): 60–75% NPC due to high TFA binding
• Moderate complexity peptides: 70–85% NPC
• Simpler sequences with few basic residues: 80–92% NPC

The practical consequence: if your research protocol requires a precise molar concentration and you dissolve your entire vial assuming 100% net content, your actual concentration will be meaningfully lower than calculated. For exploratory research this may be acceptable. For quantitative assays, binding studies, or any work requiring reproducible concentrations, it matters.

Net peptide content is determined through separate analytical methods including amino acid analysis (AAA), elemental analysis, or UV spectrophotometry. It requires its own testing step and is not derivable from the HPLC number. Many suppliers do not include it. Its presence on a COA is a positive quality signal. Its absence should prompt you to ask.

5. Additional Tests: What Premium COAs Include

Beyond HPLC purity, mass spec identity, and net peptide content, fully specified research-grade COAs may include:

Endotoxin testing: Performed using the Limulus Amebocyte Lysate (LAL) assay, this test detects bacterial lipopolysaccharides (LPS) that can trigger inflammatory responses in biological research models. Bacterial endotoxins are not detected by HPLC and will not appear in purity data. Most Research Use Only (RUO) COAs do not include endotoxin testing; it is primarily relevant for GMP-grade and clinical applications. Its presence on a research COA is a strong quality indicator.

Sterility testing: Screens for viable bacteria, yeast, and mold contamination using validated microbiological assays. Like endotoxin testing, this is primarily GMP territory but occasionally included by premium RUO suppliers.

Heavy metals testing: Detects lead, cadmium, mercury, and other heavy metals that can co-contaminate synthetic compounds from raw materials or manufacturing processes. The ACS Peptide Testing Labs dataset referenced earlier found detectable heavy metals in 17% of independently tested peptide samples (ACS Peptide Testing Labs, 2026). This is not reflected in HPLC results.

Residual solvents: Tests for traces of organic solvents (acetonitrile, methanol, DMF) remaining from synthesis. Relevant for research models sensitive to solvent effects.

Amino acid analysis (AAA): Confirms the correct ratio of each amino acid in the sequence. More common in clinical and pharmaceutical grade documentation than standard RUO COAs.

Appearance: Typically listed as "white to off-white lyophilized powder." Deviations from this (unusual color, oily texture, visible particulates) should be noted.

The Purity Number Suppliers Advertise vs. What Independent Testing Finds

The ACS Peptide Testing Labs data from 2024 to 2026 provides the most systematically documented picture of supplier COA accuracy available:

GLP-1 receptor agonist peptides (semaglutide, tirzepatide, retatrutide) showed the highest discrepancy rates at 81%, driven by demand pressure and the complexity of synthesizing longer sequences accurately (ACS Peptide Testing Labs, 2026).

The data also revealed that 34% of repeat customers found different purities across batches from the same supplier, even when those batches supposedly met identical specifications. Batch-to-batch consistency is a quality signal that a single COA cannot capture.

What this means for researchers: The COA is necessary but not sufficient. For critical research work involving sensitive assays, receptor binding studies, or quantitative protocols, independent verification through a third-party testing lab is the only way to confirm the material in your vial matches what the documentation claims.

COA Red Flags: A Practical Checklist

When evaluating any COA, run through this checklist:

Immediate red flags (stop and verify before proceeding):

• No lot number, or lot number on document does not match vial
• Purity number with no supporting methodology, chromatogram, or lab identification
• Generic COA that appears identical across multiple different peptides or batches
• Mass spec data missing entirely, or observed mass significantly different from theoretical with no explanation
• No analyst signature or laboratory identification
• Claims "pharmaceutical grade" without GMP documentation to support it
• Price is substantially below market rate for stated purity (raw materials, synthesis, and analytical testing create a cost floor that cannot be eliminated without cutting corners)

Yellow flags (ask questions before relying on this for critical work):

• In-house testing only, no third-party verification
• Purity reported without specifying the HPLC method (column type, mobile phase, gradient)
• Net peptide content absent with no explanation
• Salt form not specified
• COA date predates the stated batch by more than 12 months
• No batch consistency data or prior lot COAs available for comparison

Positive quality signals:

• Third-party ISO 17025 accredited laboratory
• Lot-matched documentation with matching vial label
• Both HPLC and MS results with actual data values (not just "pass" notation)
• Net peptide content reported alongside HPLC purity
• Chromatogram image included or available on request
• Supplier willing to answer questions about methodology
• Consistent purity results across multiple batches (not suspiciously perfect scores every time)

Research Grade vs. GMP Grade: Understanding the Difference

This distinction matters for understanding what any COA can legitimately certify.

Research Use Only (RUO) / Research Grade: Documentation confirms identity and purity using HPLC and MS. Not regulated by FDA as a drug product. Not manufactured under Good Manufacturing Practice (GMP) quality systems. The COA certifies analytical quality, not pharmaceutical compliance.

GMP Grade / API Grade: Manufactured under ICH Q7 Good Manufacturing Practice guidelines, which require validated analytical methods, full batch records, stability data, and comprehensive quality oversight systems. Required for any compound intended for human therapeutic use in clinical trials. COA documentation is substantially more extensive.

For bench research, exploratory studies, and laboratory work not involving human subjects, research-grade peptides with complete RUO COAs are appropriate. For clinical trial materials or any work moving toward regulatory submission, GMP documentation is required.

Key Insight: "Research grade" and "pharmaceutical grade" are not interchangeable terms. A supplier using them interchangeably is either confused or misleading you. Ask directly what grade of documentation applies to your batch.

How to Request and Verify a COA Before Purchase

Standard practice among serious researchers is to request the lot-specific COA before completing a purchase. Here is how to do this effectively:

Request the COA by lot number rather than asking generally for documentation. This forces the supplier to provide batch-specific data rather than a representative or template document.

Ask who performed the testing: the supplier's in-house lab or a named third-party facility. If third-party, ask for the lab name and confirm it is independently verifiable.

Verify the lot number in the COA against the lot number that will ship with your order. If the supplier cannot commit to this, or if the numbers do not match on arrival, request corrected documentation before opening the vial for research use.

For any supplier you are using for the first time on critical research, consider submitting an independent sample to a third-party testing lab. Services like Janoshik, Eurofins, and specialized peptide testing labs offer HPLC and MS analysis for individual samples. Knowing your actual purity and identity before committing experimental resources is always worth the cost.

For a practical tool to help with your peptide research preparation, see our Reconstitution Calculator for accurate vial preparation math and our Blend Ratio Calculator for multi-compound research protocols.

Research Tool: Ready to calculate your research dose based on what you know about your peptide's purity and content? Our free Reconstitution Calculator walks through the math for any vial size, solvent volume, and target concentration. Accurate preparation starts with accurate inputs.

Common COA Questions Answered

Why does my mass spec show a value roughly half of the expected molecular weight?

This is typically a doubly charged ion [M+2H]²⁺, which is common for peptides in electrospray ionization (ESI) mass spectrometry. A peptide with a theoretical mass of 3,000 Da will appear at approximately 1,501 m/z when doubly protonated. Larger peptides can appear as triply or quadruply charged species. This is normal instrument behavior, not a sign of the wrong peptide.

My COA shows 99% purity but a different supplier showed only 91% for nominally the same compound. Which is right?

Both could reflect accurate testing of their respective batches. Batch-to-batch variation is real, synthesis quality varies by manufacturer, and different HPLC methods can produce slightly different results for the same sample. The most reliable answer requires independent verification of your specific vial.

Is an in-house COA from a supplier ever acceptable?

Yes, particularly from established, reputable suppliers with a track record of transparency. The key question is not in-house vs. third-party in isolation, but whether the testing is rigorous, methodology is disclosed, and the supplier will provide lot-specific data on request. Suppliers who are evasive about this question are a more reliable warning sign than in-house testing itself.

My COA does not list net peptide content. Should I be concerned?

Not necessarily. Many legitimate RUO suppliers do not include NPC because it requires separate testing beyond HPLC/MS. The absence is worth noting and worth asking about. Its presence is a positive signal. If you are running quantitative assays where molarity precision matters, ask the supplier directly for net peptide content or run amino acid analysis independently.

What does "conforms" mean on a COA?

This notation indicates the result met the predetermined specification for that test. For example, "Appearance: white lyophilized powder — Conforms" means the physical appearance matched the stated specification. It is not a quantitative measurement and should be treated as qualitative pass/fail data only.

Understanding COA Data for Specific Peptides

Some peptide categories present additional documentation considerations:

Longer sequence peptides (CJC-1295, tesamorelin, semaglutide, retatrutide): Synthesis complexity increases with chain length. Every additional amino acid is a potential point of deletion, modification, or oxidation. MS identity confirmation is especially critical for these compounds. HPLC analysis of longer peptides may also show more complex chromatograms with related impurity peaks. For related research guides, see our CJC-1295 research guide and upcoming Semaglutide resources on the blog.

GH secretagogues (GHRP-2, GHRP-6, ipamorelin): These are relatively short sequences where synthesis errors are less common, but purity still varies significantly by supplier. The ACS data showing high GLP-1 discrepancy rates underscores that demand pressure correlates with quality shortcuts.

Cysteine-containing peptides: Cysteine is prone to oxidation and disulfide bond formation during synthesis and storage. A good COA for cysteine-rich peptides will note oxidation status and may include specific testing for dimer formation.

For peptide-specific terminology and sequence information, our Peptide Glossary covers 55+ terms including structural features relevant to quality assessment.

Trust but Verify: For high-stakes research requiring accurate concentrations, consider submitting a sample from any new supplier to an independent testing lab before committing experimental resources. A single test can confirm or dispute months of assumed data quality. It is almost always worth the cost.

Conclusion: The COA as a Research Foundation, Not a Finish Line

Every researcher's relationship with peptide quality documentation should start the same way: with the understanding that a COA is evidence of testing, not a guarantee of quality. The document is only as reliable as the lab that produced it, the methodology used, and the honesty of the supplier who commissioned it.

The core framework this guide covers:

• Verify the lot number match before everything else
• HPLC purity measures peptide content relative to other peptide-related impurities, not total vial content
• Net peptide content is the number that actually drives accurate dosing math
• Mass spectrometry is required for sequence identity confirmation, HPLC alone cannot do this
• Third-party ISO 17025-accredited testing provides the highest confidence
• 73% discrepancy rate in independent verification data means supplier COAs require scrutiny, not blind acceptance
• Red flags are cumulative: one yellow flag is a question mark, multiple yellow flags are a pattern

As the peptide research space grows and more compounds enter mainstream biohacking culture, documentation literacy is one of the most protective skills a serious researcher can develop. Knowing how to read a COA well does not just protect experimental integrity. It is the difference between researching what you think you have and actually researching what you have.

For more foundational research methodology content, explore our Peptide Glossary and research tools. And if you want weekly deep-dives on peptide science, compound profiles, and quality frameworks, join the PeptideUnlock newsletter.

Final Note: Research peptides carry risks and are not intended for human consumption outside regulated studies. Individual results vary. This article is based on publicly available scientific literature and user-reported experiences — it is not a substitute for professional medical guidance.

References

1. ACS Peptide Testing Labs. (2026). Common peptide purity discrepancies: What our lab data reveals. https://acslabtest.com/blog/common-peptide-purity-discrepancies-lab-data
2. Numan, S. (2025, August 7). Certificates of analysis: What researchers need to know. Verified Peptides Knowledge Hub. https://verifiedpeptides.com/knowledge-hub/certificates-of-analysis-what-researchers-need-to-know/
3. Numan, S. (2025, August 21). Decoding lab reports: Peptide verification report metrics. Verified Peptides Knowledge Hub. https://verifiedpeptides.com/knowledge-hub/decoding-lab-reports-peptide-verification-report-metrics/
4. Honest Peptide. (2025, November 26). How to read a peptide COA (real vs fake). https://honestpeptide.com/research/how-to-read-a-peptide-coa
5. PeptideSystems. (2025, December 17). Certified peptides: A complete scientific guide to authentic, verified research-grade peptides. https://www.peptidesystems.com/post/certified-peptides-a-complete-scientific-guide-to-authentic-verified-research-grade-peptides
6. Vanguard Laboratory. (2025, December 8). The ultimate guide to HPLC testing for peptides. https://vanguardlaboratory.com/2025/12/08/the-ultimate-guide-to-hplc-testing-for-peptides/
7. BodySpec. (2026). Peptide Sciences: Guide to quality, purity & safe buying. https://www.bodyspec.com/blog/post/peptide_sciences_guide_to_quality_purity_safe_buying
8. Spartan Peptides. (2025, October 12). Quality control in peptide research: Interpreting HPLC and mass spec purity. https://spartanpeptides.com/blog/quality-control-peptide-research-interpreting-purity/
9. BioLongevity Labs. (2025). How to read peptide COAs and verify supplier quality. https://biolongevitylabs.com/quality/how-to-read-peptide-coa-quality/
10. Cernum Biosciences. (2026, January 9). How to spot fake peptide suppliers in 2026: 9 red flags. https://cernumbiosciences.com/blogs/peptide-science-guide/how-to-spot-fake-peptide-suppliers-in-2026-9-red-flags
11. PeptideDeck. (2025). How to read a peptide COA: Complete guide. https://www.peptidedeck.com/blog/how-to-read-peptide-coa-certificate-of-analysis
12. Verified Peptides. (2025, August 4). Peptide quality: Importance of third-party validation. https://verifiedpeptides.com/knowledge-hub/why-laboratory-validation-matters-in-peptide-quality/
13. United States Pharmacopeia. General Chapter <1043>: Ancillary Materials for Cell, Gene, and Tissue-Engineered Products. (2021). https://www.usp.org
14. Pennington, M. W. et al. (2021). Peptide therapeutics and analytical methods. Medicine in Drug Discovery, 9, 100071.